GGrantIndex
← Leaderboards

Darrell J Triulzi

University Of Pittsburgh At Pittsburgh

$6,789,583
Attributed
$10,988,036
Total exposure
6
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.9M · FY200522
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$10,988,036 · 6

By mechanism

UH3$6,343,534 · 1
U01$2,019,185 · 1
UG3$1,459,550 · 1
R34$593,822 · 1
N01$553,625 · 1
M01$18,320 · 1

Top collaborators

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Trials

Research focus

Clinical TrialsBloodHospitalsTransfusionClinical ResearchAdultSafetyStandard Of CareProtocols DocumentationOrganPlasmaPreventCessation Of LifeMorbidity - Disease RateMortalityTherapeutic InterventionAccident And Emergency DepartmentErythrocytesAcuteHealthcareFunctional DisorderOperative Surgical ProceduresResourcesHemostatic Agents

Grant awards (18)

1/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)$680,622
UH3 · FY2022 · HL
1/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)$2,887,088
UH3 · FY2021 · HL
1/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)$2,775,824
UH3 · FY2020 · HL
1/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)$1,459,550
UG3 · FY2019 · HL
Pragmatic, Prehospital Group O Whole Blood Early Resuscitation Pilot Trial$197,845
R34 · FY2019 · HL
Pragmatic, Prehospital Group O Whole Blood Early Resuscitation Pilot Trial$197,759
R34 · FY2018 · HL
Pragmatic, Prehospital Group O Whole Blood Early Resuscitation Pilot Trial$198,218
R34 · FY2017 · HL
Transfusion Medicine/Hemostasis Clinical Research Network$162,422
U01 · FY2012 · HL · contact PI
Retrovirus Epidemiology Donor Study-II (REDS-II) Blood Center$383,135
N01 · FY2010 · HL · contact PI
Transfusion Medicine/Hemostasis Clinical Research Network$185,625
U01 · FY2009 · HL · contact PI
Retrovirus Epidemiology Donor Study-II (REDS-II) Blood Center$170,490
N01 · FY2009 · HL · contact PI
Transfusion Medicine/Hemostasis Clinical Research Network$185,625
U01 · FY2007 · HL · contact PI
Transfusion Medicine/Hemostasis Clinical Research Netwo*$292,939
U01 · FY2006 · HL · contact PI
Transfusion Medicine/Hemostasis Clinical Research Netwo*$299,820
U01 · FY2005 · HL
DETERM OPTIMAL PROPHYLACTIC PLATLET STRATEGY PREVNT BLEED'G THROMBOCYTOPERIC$18,320
M01 · FY2005 · RR
Transfusion Medicine/Hemostasis Clinical Research Netwo*$298,109
U01 · FY2004 · HL
Transfusion Medicine/Hemostasis Clinical Research Netwo*$294,705
U01 · FY2003 · HL
Transfusion Medicine/Hemostasis Clinical Research Netwo*$299,940
U01 · FY2002 · HL